Steven Insoft - Omega Healthcare Chief Corporate Development Officer
| OHI Stock | USD 31.27 0.58 1.89% |
Executive
Mr. Steven J. Insoft is the Chief Corporationrationrate Development Officer of Omega Healthcare Investors, Inc. Mr. Insoft is our Chief Corporationrationrate Development Officer and has served in this capacity since April 1, 2015. Mr. Insoft served as President and Chief Operating Officer of Aviv REIT, Inc. since 2012, while previously serving as Chief Financial Officer and Treasurer. Prior to joining Aviv REIT, Inc. in 2005, Mr. Insoft spent eight years as a Vice President and Senior Investment Officer of Nationwide Health Properties, Inc., a publiclytraded REIT. Before that, he was President and Chief Financial Officer of CMI Senior Housing Healthcare, Inc., a privatelyheld nursing home and assisted living facility operations and development company, for seven years. since 2015.
| Age | 55 |
| Tenure | 9 years |
| Professional Marks | MBA |
| Address | 303 International Circle, Hunt Valley, MD, United States, 21030-1394 |
| Phone | 410 427 1700 |
| Web | https://www.omegahealthcare.com |
Omega Healthcare Management Efficiency
The company has Return on Asset of 0.033 % which means that on every $100 spent on assets, it made $0.033 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0658 %, implying that it generated $0.0658 on every 100 dollars invested. Omega Healthcare's management efficiency ratios could be used to measure how well Omega Healthcare manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to 0.03. The current Return On Capital Employed is estimated to decrease to 0.08. As of now, Omega Healthcare's Other Assets are increasing as compared to previous years. The Omega Healthcare's current Total Current Assets is estimated to increase to about 2.4 B, while Intangible Assets are projected to decrease to under 647.9 K.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Michelle Kelly | National Health Investors | N/A | |
| Christian Cummings | Ventas Inc | 50 | |
| Robert McCadden | Universal Health Realty | 62 | |
| Susan Sidwell | National Health Investors | N/A | |
| James Callister | CareTrust REIT | 48 | |
| Jeffrey Miller | Healthpeak Properties | 64 | |
| Richard Weiss | Healthpeak Properties | 74 | |
| Roger Hopkins | National Health Investors | 56 | |
| Peter Scott | Healthpeak Properties | 44 | |
| Jameson Bennett | Healthpeak Properties | N/A | |
| Gayle Capozzalo | Universal Health Realty | 70 | |
| Richard JD | Ventas Inc | 66 | |
| Peter Nyland | Sabra Healthcare REIT | N/A | |
| Julie Robinson | Ventas Inc | N/A | |
| Miles Berger | Universal Health Realty | 58 | |
| Albert Black | Healthpeak Properties | 61 | |
| Shawn Johnston | Healthpeak Properties | 44 | |
| Elliot Sussman | Universal Health Realty | 64 | |
| Adam Mabry | Healthpeak Properties | 39 | |
| Justin Hutchens | Ventas Inc | 49 | |
| Daniel JD | Healthpeak Properties | 59 | |
Management Performance
| Return On Equity | 0.0658 | ||||
| Return On Asset | 0.033 |
Omega Healthcare Inv Leadership Team
Elected by the shareholders, the Omega Healthcare's board of directors comprises two types of representatives: Omega Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Omega. The board's role is to monitor Omega Healthcare's management team and ensure that shareholders' interests are well served. Omega Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Omega Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Norman Bobins, Independent Director | ||
| Craig Bernfield, Director | ||
| Taylor CPA, CEO Director | ||
| Matthew Gourmand, IR Contact Officer | ||
| Thomas Peterson, IR Contact Officer | ||
| Burke Whitman, Independent Director | ||
| Craig Callen, Independent Chairman of the Board | ||
| Samuel Kovitz, Senior VP | ||
| Daniel Booth, Chief Operating Officer | ||
| Michael Ritz, Chief Accounting Officer | ||
| Barbara Hill, Independent Director | ||
| Vikas Gupta, Senior Development | ||
| Harold Kloosterman, Independent Director | ||
| Ben Perks, Director | ||
| Kapila Anand, Independent Director | ||
| Neal Ballew, Senior Vice President Chief Accounting Officer | ||
| Edward Lowenthal, Independent Director | ||
| Benjamin Perks, Independent Director | ||
| Bernard Korman, Independent Chairman of the Board | ||
| Thomas Franke, Independent Director | ||
| C Pickett, Chief Executive Officer, Director | ||
| Kevin Jacobs, Independent Director | ||
| Megan Krull, Senior Operations | ||
| Michele Reber, Director Management | ||
| Robert Stephenson, Chief Financial Officer | ||
| Steven Insoft, Chief Corporate Development Officer | ||
| Gail Makode, Chief Legal Officer, General Counsel | ||
| Stephen Plavin, Independent Director | ||
| Taylor Pickett, CEO, Director | ||
| Lisa EgbuonuDavis, Director |
Omega Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Omega Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0658 | ||||
| Return On Asset | 0.033 | ||||
| Profit Margin | 0.26 % | ||||
| Operating Margin | 0.46 % | ||||
| Current Valuation | 12.38 B | ||||
| Shares Outstanding | 246.93 M | ||||
| Shares Owned By Insiders | 0.29 % | ||||
| Shares Owned By Institutions | 66.62 % | ||||
| Number Of Shares Shorted | 13.4 M | ||||
| Price To Earning | 30.17 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Omega Healthcare Investors. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the Omega Healthcare Inv information on this page should be used as a complementary analysis to other Omega Healthcare's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Complementary Tools for Omega Stock analysis
When running Omega Healthcare's price analysis, check to measure Omega Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Omega Healthcare is operating at the current time. Most of Omega Healthcare's value examination focuses on studying past and present price action to predict the probability of Omega Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Omega Healthcare's price. Additionally, you may evaluate how the addition of Omega Healthcare to your portfolios can decrease your overall portfolio volatility.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |
Is Omega Healthcare's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Omega Healthcare. If investors know Omega will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Omega Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.148 | Dividend Share 2.68 | Earnings Share 1 | Revenue Per Share 3.949 | Quarterly Revenue Growth 0.652 |
The market value of Omega Healthcare Inv is measured differently than its book value, which is the value of Omega that is recorded on the company's balance sheet. Investors also form their own opinion of Omega Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Omega Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Omega Healthcare's market value can be influenced by many factors that don't directly affect Omega Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Omega Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Omega Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Omega Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.